Anti-inflammatory effect of MAPK phosphatase-1 local gene transfer in inflammatory bone loss
Authors:
- 11 November 2010
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 18 (4) , 344-353
Abstract
Alveolar bone loss associated with periodontal diseases is the result of osteoclastogenesis induced by bacterial pathogens. The mitogen-activated protein kinase (MAPK) phosphatase 1 (MKP-1) is a critical negative regulator of immune response as a key phosphatase capable of dephosphorylating activated MAPKs. In this study, rat macrophages transduced with recombinant adenovirus (Ad.)MKP-1 specifically dephosphorylated activated MAPKs induced by lipopolysaccharide (LPS) compared with control cells. Bone marrow macrophages from MKP-1 knockout (KO) mice exhibited higher interleukin (IL)-6, IL-10, tumor necrosis factor (TNF)-α, and select chemokine compared with wild-type (WT) mice when stimulated by LPS. In addition, bone marrow cultures from MKP-1 KO mice exhibited significantly more osteoclastogenesis induced by LPS than when compared with WT mice. Importantly, MKP-1 gene transfer in bone marrow cells of MKP-1 KO mice significantly decreased IL-6, IL-10, TNF-α and chemokine levels, and formed fewer osteoclasts induced by LPS than compared with control group of cells. Furthermore, MKP-1 gene transfer in an experimental periodontal disease model attenuated bone resorption induced by LPS. Histological analysis confirmed that periodontal tissues transduced with Ad. MKP-1 exhibited less infiltrated inflammatory cells, less osteoclasts and less IL-6 than compared with rats of control groups. These studies indicate that MKP-1 is a key therapeutic target to control of inflammation-induced bone loss.Keywords
This publication has 37 references indexed in Scilit:
- MAP Kinase Phosphatase-1 Protects against Inflammatory Bone LossJournal of Dental Research, 2009
- Role of MKP-1 in Osteoclasts and Bone HomeostasisThe American Journal of Pathology, 2009
- Targeting mRNA Stability Arrests Inflammatory Bone LossMolecular Therapy, 2008
- A p38 Mitogen‐Activated Protein Kinase Inhibitor Arrests Active Alveolar Bone Loss in a Rat Periodontitis ModelJournal of Periodontology, 2007
- Regulation of innate immune response by MAP kinase phosphatase-1Cellular Signalling, 2007
- Pseudomonas aeruginosa Lipopolysaccharide Induces Osteoclastogenesis Through a Toll‐Like Receptor 4 Mediated Pathway in Vitro and in VivoThe Laryngoscope, 2007
- Osteoclasts: What Do They Do and How Do They Do It?The American Journal of Pathology, 2007
- MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shockJournal of Experimental Medicine, 2005
- Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP‐1 and RANTESJournal of Cellular Biochemistry, 2005
- Regulatory Mechanisms Operative in OsteoclastsCritical Reviews™ in Eukaryotic Gene Expression, 2004